Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

<p>Immunologic pathway genes</p>

Uloženo v:
Podrobná bibliografie
Hlavní autor: Alexander N. Shoushtari (15023909) (author)
Další autoři: Anthony J. Olszanski (15031292) (author), Marta Nyakas (15051200) (author), Thomas J. Hornyak (15051203) (author), Jedd D. Wolchok (15032924) (author), Victor Levitsky (15051206) (author), Lukasz Kuryk (15051209) (author), Thomas B. Hansen (15051212) (author), Magnus Jäderberg (15051215) (author)
Vydáno: 2025
Témata:
Cancer
Tumor Biology
Clinical Research and Trials
Clinical-Stage Research
Skin Cancers
Melanoma
Tumor Microenvironment
Immune cells and the microenvironment
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky